A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.
Saved in:
| Title: | A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma. |
|---|---|
| Authors: | Burge ME; Cancer Research UK Clinical Centre, University of Leeds, Cookridge Hospital, Leeds, UK., Smith D, Topham C, Jackson DP, Anthoney DA, Halstead F, Seymour MT |
| Source: | British journal of cancer [Br J Cancer] 2006 May 08; Vol. 94 (9), pp. 1281-6. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium: Print ISSN: 0007-0920 (Print) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 16622464 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Burge+ME%22">Burge ME</searchLink>; Cancer Research UK Clinical Centre, University of Leeds, Cookridge Hospital, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Smith+D%22">Smith D</searchLink><br /><searchLink fieldCode="AU" term="%22Topham+C%22">Topham C</searchLink><br /><searchLink fieldCode="AU" term="%22Jackson+DP%22">Jackson DP</searchLink><br /><searchLink fieldCode="AU" term="%22Anthoney+DA%22">Anthoney DA</searchLink><br /><searchLink fieldCode="AU" term="%22Halstead+F%22">Halstead F</searchLink><br /><searchLink fieldCode="AU" term="%22Seymour+MT%22">Seymour MT</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2006 May 08; Vol. 94 (9), pp. 1281-6. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0007-0920 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=16622464 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/sj.bjc.6603084 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1281 Titles: – TitleFull: A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burge ME – PersonEntity: Name: NameFull: Smith D – PersonEntity: Name: NameFull: Topham C – PersonEntity: Name: NameFull: Jackson DP – PersonEntity: Name: NameFull: Anthoney DA – PersonEntity: Name: NameFull: Halstead F – PersonEntity: Name: NameFull: Seymour MT IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 05 Text: 2006 May 08 Type: published Y: 2006 Identifiers: – Type: issn-print Value: 0007-0920 Numbering: – Type: volume Value: 94 – Type: issue Value: 9 Titles: – TitleFull: British journal of cancer Type: main |
| ResultId | 1 |
